Trial Profile
Clinical and Biologic Evaluation of Polyphenon E, an Extract of Green Tea Containing EGCG, In Plasma Cell Dyscrasias- Pilot Study
Status:
Discontinued
Phase of Trial:
Phase II
Latest Information Update: 07 Aug 2015
Price :
$35
*
At a glance
- Drugs Polyphenon E (Primary)
- Indications Smoldering multiple myeloma; Tumours
- Focus Therapeutic Use
- 21 Jun 2012 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 09 May 2012 New trial record